GlassScriptPhysician profile
Michael D Gillett
NPI 1619954542
$713.22
in general payments reported to CMS, 2019-2025
15 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.08 · 2021: $27.91 · 2022: $80.83 · 2023: $49.71 · 2024: $332 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $144.94 | 2019-2024 | Lumenis Pulse 120h |
| Procept Biorobotics Corporation | $124.83 | 2024 | Aquabeam System |
| Janssen Biotech, INC. | $71.54 | 2025 | Erleada |
| Astellas Pharma US INC | $59.40 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $55.47 | 2024 | Lynparza |
| Sumitomo Pharma America, INC. | $54.83 | 2024-2025 | Orgovyx |
| Endo Pharmaceuticals INC. | $46.17 | 2022-2023 | Xiaflex |
| Novartis Pharmaceuticals Corporation | $42.89 | 2023-2025 | |
| Pfizer INC. | $20.09 | 2025 | |
| Medtronic, INC. | $18.93 | 2022 | |
| 180 Medical, INC. | $16.74 | 2019 | |
| Palette Life Sciences, INC. | $16.57 | 2022 | |
| Myovant Sciences INC. | $15.03 | 2021 | |
| Laborie Medical Technologies Corp. | $12.91 | 2022 | |
| Allergan, INC. | $12.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gillett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.